Madayln Kalmar
Family · Pittsburgh, PANPI 1720558356
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novo Nordisk at 28.2% of the total. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$654
- Dexcom, Inc.$418
- Antares Pharma, Inc.$231
- Cequr Corporation$150
- Abbott$138
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,835100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 83 | $1,082 |
| Lilly USA, LLC | 32 | $654 |
| Dexcom, Inc. | 27 | $418 |
| Antares Pharma, Inc. | 13 | $231 |
| Cequr Corporation | 2 | $150 |
| Abbott | 9 | $138 |
| Bayer | 6 | $123 |
| Chiesi USA, Inc. | 5 | $109 |
| Ascendis Pharma Endocrinology Inc | 5 | $99 |
| Boehringer Ingelheim | 5 | $98 |
| Pfizer | 4 | $91 |
| Amarin Pharma, Inc. | 4 | $82 |
| Madrigal Pharmaceuticals | 3 | $74 |
| Tandem Diabetes Care, Inc. | 6 | $64 |
| Recordati_rare_diseases_inc. | 3 | $60 |
| IBSA Pharma Inc. | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Acella Pharmaceuticals, LLC | 2 | $43 |
| Radius Health, Inc. | 2 | $42 |
| Novartis | 2 | $39 |
| AstraZeneca | 2 | $31 |
| Halozyme Inc | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$136
How this compares
$3,835 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,501 |
| Levothyroxine Sodium | 19 | $94 |
Paid to pharmacies, not to this prescriber.
Other family in Pittsburgh
- Kathleen ScholzPittsburgh$397K
- Kweilynn GreenePittsburgh$139K
- Margaret RosenzweigPittsburgh$89K
- Patricia HabdasPittsburgh$83K
- Morgan ColePittsburgh$41K
- Amber GrinnellPittsburgh$33K
- Matthew BarnesPittsburgh$25K
- Alexander TatangeloPittsburgh$20K
- Sydney MurrayPittsburgh$19K
- Renee ConnPittsburgh$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.